Suchergebnisse - (Subject:"antiviral")

PubPharm (127.113)

31

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply

enthalten in: The New England journal of medicine | 2024

von Wang, Y. | Hu, H. | Cao, B.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

32

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Selvi-Sabater, P. | de la Rubia Ortí, J. | Urbieta-Sanz, E.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

33

Interferon-γ+ Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization

enthalten in: Journal of medical virology | 2024

von Wu, L. | Deng, H. | Feng, X. | +12

34

Design, Synthesis and Anti-PVY Activity of Planar Chiral Thiourea Derivatives Incorporated with [2.2]Paracyclophane

enthalten in: Pest management science | 2024

von Shu, L. | Lv, Y. | Chen, Z. | +5

35

Antiviral screening of natural, anti-inflammatory compound library against African swine fever virus

enthalten in: Virology journal | 2024

von Jackman, J. | Hakobyan, A. | Grigoryan, R. | +3

36

Effect of acyclovir therapy on the outcome of mechanically ventilated patients with lower respiratory tract infection and detection of herpes simplex virus in bronchoalveolar lavage : protocol for a multicentre, randomised controlled trial (HerpMV)

enthalten in: BMJ open | 2024

von Hagel, S. | Brillinger, N. | Decker, S. | +46

37

SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines : Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?

enthalten in: Antiviral research | 2024

von Ameratunga, R. | Jordan, A. | Lehnert, K. | +5

38

Antiviral screening of natural, anti-inflammatory compound library against African swine fever virus

enthalten in: Virology journal | 2024

von Jackman, J. | Hakobyan, A. | Grigoryan, R. | +3

39

A guide to COVID-19 antiviral therapeutics : a summary and perspective of the antiviral weapons against SARS-CoV-2 infection

enthalten in: The FEBS journal | 2024

von Brady, D. | Gurijala, A. | Huang, L. | +7

40

Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans : an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

enthalten in: EBioMedicine | 2024

von Chen, K. | Jackson, N. | Kelesidis, T.